(S)-LG-120746
Alternative Names: LG-120746-(S)Latest Information Update: 07 Feb 2001
At a glance
- Originator Ligand Pharmaceuticals
- Class
- Mechanism of Action Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Menopausal syndrome
Most Recent Events
- 07 Feb 2001 Discontinued-Preclinical for Menopausal syndrome in USA (PO)
- 26 Mar 1999 New profile
- 26 Mar 1999 Preclinical development for Menopausal syndrome in USA (PO)